mdf commerce annonce la date de la conférence téléphonique sur les résultats financiers du troisième trimestre de l'exercice 2024
30 janv. 2024 08h00 HE
|
mdf commerce inc.
MONTRÉAL, 30 janv. 2024 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX:MDF), un leader des technologies de commerce électronique de type logiciel-service (« SaaS »), tiendra une conférence...
mdf commerce announces the date of the conference call for third quarter of fiscal year 2024 financial results
30 janv. 2024 08h00 HE
|
mdf commerce inc.
MONTREAL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX: MDF), a SaaS leader in digital commerce technologies, will hold a conference call to discuss third quarter of fiscal year 2024...
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
05 janv. 2024 09h30 HE
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
05 janv. 2024 09h30 HE
|
OKYO Pharma LTD
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
Fortuna to attend Scotiabank Mining Conference
20 nov. 2023 05h00 HE
|
Fortuna Silver Mines Inc.
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce that it will be attending the Scotiabank Mining Conference,...
Tiziana Life Sciences to Present Recent Clinical Updates at BIO-Europe in Munich, Germany, November 6-8, 2023
01 nov. 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress
11 oct. 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
Treatment Of Six Non-Active Secondary Progressive MS With Nasal Anti-CD3 Monoclonal Antibody (Foralumab): Safety, Biomarker, And Disability Outcomes
Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
08 sept. 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at the Annual Meeting of the International Society of Neuroimmunology
23 août 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Dr. Patrick Gruber to Participate in a Water Tower Research Fireside Chat on Thursday, August 17th at 4:00 pm ET
15 août 2023 16h01 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced today that Dr. Patrick Gruber, Chief Executive Officer, will participate in a Water Tower Research Fireside...